Product
Regulatory T cells
1 clinical trial
2 indications
Indication
ulcerative colitisIndication
Autoimmune DiseasesClinical trial
Phase I, Open-label, Fast-track Dose-escalation Clinical Trial Exploring the Safety and the Tolerability of Autologous ex Vivo Expanded Regulatory T Cells in Adults With Ulcerative ColitisStatus: Completed, Estimated PCD: 2023-04-12